Clinical Trials Browser

Lymphoma × R-CHOP protocol × 90 days × Clear all

NCT04546620 2026-04-30

REMoDL-A

Phase 2 Active not recruiting

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse